This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

UPS Survey: Product Protection Rises As A Top Supply Chain Concern Among Healthcare Execs

U.S.-based decision-makers also were asked their views on the state of the healthcare industry against the goals of the new reform law. The largest group – 38 percent – are “cautiously optimistic” of progress, yet 26 percent espouse a “negative” view while another 22 percent say they are “neutral.”

Five-year trends

Over the past five years, a top trend in the healthcare industry has been increasing global growth with companies ramping up expansion into new markets each year. With the rise of increasing globalization, healthcare executives have reported growing concerns around the areas of product protection and intellectual property protection. Product protection concerns include both product security and the issue of product damage and spoilage. Concerns around intellectual property protection have grown every year for the past three years.

The survey’s five-year data also illustrates the “constants” in the industry that have continued to challenge healthcare supply chain decision makers. Concerns around cost management and regulatory compliance top the list of industry constants over the past five years.

“The five-year survey trends underscore what we are hearing from all segments of the healthcare marketplace,” said Hook. “From industry leaders to middle market companies, healthcare companies are looking for ways to be more collaborative, provide integrated solutions and address segmentation issues around their customers. This information has been critical in continuing UPS’s success as a global leader in healthcare logistics.”

For more information on the findings of the UPS Pain in the Chain survey and to download an executive summary and special five-year report, visit

UPS (NYSE:UPS) is a global leader in logistics, offering a broad range of solutions including the transportation of packages and freight; the facilitation of international trade, and the deployment of advanced technology to more efficiently manage the world of business. Headquartered in Atlanta, UPS serves more than 220 countries and territories worldwide. The company can be found on the Web at and its corporate blog can be found at To get UPS news direct, visit

Editor’s note:

Survey Methodology

The UPS Pain in the (Supply) Chain survey was a blind, in-depth phone survey conducted by TNS on behalf of UPS of approximately 375 healthcare executives in the U.S., Western Europe, Asia and Latin America. Qualified respondents were senior-level decision-makers responsible for supply chain and logistics in the pharmaceutical, medical device and biotech industries. Surveys were conducted in April and May 2012.

3 of 4

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.99 0.31%
FB $103.10 1.20%
GOOG $687.12 0.59%
TSLA $148.75 -1.10%
YHOO $26.96 0.75%


Chart of I:DJI
DOW 15,893.71 +233.53 1.49%
S&P 500 1,847.89 +18.81 1.03%
NASDAQ 4,294.0220 +27.1850 0.64%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs